Annual D&A
$1.68 M
-$3.54 M-67.82%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual depreciation & amortization is $1.68 million, with the most recent change of -$3.54 million (-67.82%) on December 31, 2023.
- During the last 3 years, OCX annual D&A has risen by +$1.29 million (+326.40%).
- OCX annual D&A is now -67.82% below its all-time high of $5.22 million, reached on December 31, 2022.
Performance
OCX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$340.00 K
+$14.00 K+4.29%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly depreciation & amortization is $340.00 thousand, with the most recent change of +$14.00 thousand (+4.29%) on September 30, 2024.
- Over the past year, OCX quarterly D&A has dropped by -$86.00 thousand (-20.19%).
- OCX quarterly D&A is now -75.13% below its all-time high of $1.37 million, reached on September 30, 2022.
Performance
OCX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.33 M
-$86.00 K-6.09%
September 30, 2024
Summary
- As of February 8, 2025, OCX TTM depreciation & amortization is $1.33 million, with the most recent change of -$86.00 thousand (-6.09%) on September 30, 2024.
- Over the past year, OCX TTM D&A has dropped by -$1.31 million (-49.64%).
- OCX TTM D&A is now -74.60% below its all-time high of $5.22 million, reached on December 31, 2022.
Performance
OCX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
OCX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.8% | -20.2% | -49.6% |
| 3 y3 years | +326.4% | -75.0% | -73.9% |
| 5 y5 years | +200.5% | -75.0% | -73.9% |
OCX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.8% | at low | -75.1% | +4.6% | -74.6% | at low |
| 5 y | 5-year | -67.8% | +378.6% | -75.1% | +129.5% | -74.6% | +277.8% |
| alltime | all time | -67.8% | +506.5% | -75.1% | +129.5% | -74.6% | +1741.7% |
OncoCyte Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $340.00 K(+4.3%) | $1.33 M(-6.1%) |
| Jun 2024 | - | $326.00 K(-2.7%) | $1.41 M(-8.5%) |
| Mar 2024 | - | $335.00 K(+3.1%) | $1.54 M(-8.2%) |
| Dec 2023 | $1.68 M(-67.8%) | $325.00 K(-23.7%) | $1.68 M(-36.2%) |
| Sep 2023 | - | $426.00 K(-6.8%) | $2.63 M(-26.3%) |
| Jun 2023 | - | $457.00 K(-3.2%) | $3.57 M(-20.2%) |
| Mar 2023 | - | $472.00 K(-63.1%) | $4.48 M(-14.2%) |
| Dec 2022 | $5.22 M(+24.1%) | $1.28 M(-6.5%) | $5.22 M(+0.5%) |
| Sep 2022 | - | $1.37 M(+0.5%) | $5.19 M(+2.4%) |
| Jun 2022 | - | $1.36 M(+11.9%) | $5.07 M(+1.6%) |
| Mar 2022 | - | $1.22 M(-3.0%) | $4.99 M(+18.7%) |
| Dec 2021 | $4.21 M(+967.3%) | $1.25 M(+0.6%) | $4.21 M(+133.6%) |
| Sep 2021 | - | $1.25 M(-2.7%) | $1.80 M(+10.0%) |
| Jun 2021 | - | $1.28 M(+199.1%) | $1.64 M(+175.1%) |
| Mar 2021 | - | $428.00 K(-137.1%) | $595.00 K(+51.0%) |
| Dec 2020 | $394.00 K(+12.3%) | -$1.15 M(-206.6%) | $394.00 K(-75.7%) |
| Sep 2020 | - | $1.08 M(+354.6%) | $1.62 M(+160.5%) |
| Jun 2020 | - | $238.00 K(+4.8%) | $622.00 K(+32.9%) |
| Mar 2020 | - | $227.00 K(+211.0%) | $468.00 K(+33.3%) |
| Dec 2019 | $351.00 K | $73.00 K(-13.1%) | $351.00 K(-12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $84.00 K(0.0%) | $399.00 K(-6.1%) |
| Jun 2019 | - | $84.00 K(-23.6%) | $425.00 K(-15.8%) |
| Mar 2019 | - | $110.00 K(-9.1%) | $505.00 K(-9.7%) |
| Dec 2018 | $559.00 K(-3.6%) | $121.00 K(+10.0%) | $559.00 K(-6.8%) |
| Sep 2018 | - | $110.00 K(-32.9%) | $600.00 K(-6.7%) |
| Jun 2018 | - | $164.00 K(0.0%) | $643.00 K(+4.4%) |
| Mar 2018 | - | $164.00 K(+1.2%) | $616.00 K(+6.2%) |
| Dec 2017 | $580.00 K(+49.9%) | $162.00 K(+5.9%) | $580.00 K(+11.1%) |
| Sep 2017 | - | $153.00 K(+11.7%) | $522.00 K(+9.4%) |
| Jun 2017 | - | $137.00 K(+7.0%) | $477.00 K(+7.4%) |
| Mar 2017 | - | $128.00 K(+23.1%) | $444.00 K(+14.7%) |
| Dec 2016 | $387.00 K(+36.7%) | $104.00 K(-3.7%) | $387.00 K(+9.6%) |
| Sep 2016 | - | $108.00 K(+3.8%) | $353.00 K(+11.7%) |
| Jun 2016 | - | $104.00 K(+46.5%) | $316.00 K(+12.1%) |
| Mar 2016 | - | $71.00 K(+1.4%) | $282.00 K(-0.4%) |
| Dec 2015 | $283.00 K(+0.7%) | $70.00 K(-1.4%) | $283.00 K(+32.9%) |
| Sep 2015 | - | $71.00 K(+1.4%) | $213.00 K(+50.0%) |
| Jun 2015 | - | $70.00 K(-2.8%) | $142.00 K(+97.2%) |
| Mar 2015 | - | $72.00 K | $72.00 K |
| Dec 2014 | $281.00 K(+1.4%) | - | - |
| Dec 2013 | $277.00 K | - | - |
FAQ
- What is OncoCyte annual depreciation & amortization?
- What is the all time high annual D&A for OncoCyte?
- What is OncoCyte annual D&A year-on-year change?
- What is OncoCyte quarterly depreciation & amortization?
- What is the all time high quarterly D&A for OncoCyte?
- What is OncoCyte quarterly D&A year-on-year change?
- What is OncoCyte TTM depreciation & amortization?
- What is the all time high TTM D&A for OncoCyte?
- What is OncoCyte TTM D&A year-on-year change?
What is OncoCyte annual depreciation & amortization?
The current annual D&A of OCX is $1.68 M
What is the all time high annual D&A for OncoCyte?
OncoCyte all-time high annual depreciation & amortization is $5.22 M
What is OncoCyte annual D&A year-on-year change?
Over the past year, OCX annual depreciation & amortization has changed by -$3.54 M (-67.82%)
What is OncoCyte quarterly depreciation & amortization?
The current quarterly D&A of OCX is $340.00 K
What is the all time high quarterly D&A for OncoCyte?
OncoCyte all-time high quarterly depreciation & amortization is $1.37 M
What is OncoCyte quarterly D&A year-on-year change?
Over the past year, OCX quarterly depreciation & amortization has changed by -$86.00 K (-20.19%)
What is OncoCyte TTM depreciation & amortization?
The current TTM D&A of OCX is $1.33 M
What is the all time high TTM D&A for OncoCyte?
OncoCyte all-time high TTM depreciation & amortization is $5.22 M
What is OncoCyte TTM D&A year-on-year change?
Over the past year, OCX TTM depreciation & amortization has changed by -$1.31 M (-49.64%)